# BY002 IIT Study in R/R Acute Leukemia

> **NCT07270770** · PHASE1 · RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 18 (estimated)

## Conditions studied

- Acute Leukemia
- KMT2A Rearrangements or NPM1 Mutations Acute Leukemia

## Interventions

- **DRUG:** BY002

## Key facts

- **NCT ID:** NCT07270770
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-15
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07270770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07270770, "BY002 IIT Study in R/R Acute Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07270770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*